Pharvaris (PHVS) Change in Receivables (2020 - 2026)

Pharvaris has reported Change in Receivables for 7 years, with the latest figure at -$335027.6 in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 154.22% year-over-year to -$335027.6; the trailing twelve-month figure through Mar 2026 stood at $2.7 billion (up 39.82% YoY), and the FY2025 full-year result was -$374350.5, down 907.9% from the prior year.
• Change in Receivables for Q1 2026 stood at -$335027.6, up from -$453000.3 in the prior quarter.
• The five-year high for Change in Receivables was $100.8 billion in Q3 2024, with the low at -$98.8 billion in Q2 2024.
• Historically, Change in Receivables has averaged $277.1 million across 5 years, with a median of -$12465.8 in 2023.
• The largest YoY upside for Change in Receivables was 14582576.89% in 2023 against a maximum downside of 72003334.17% in 2023.
• Pharvaris' Change in Receivables stood at $22127.1 in 2022, then plunged by 657.61% to -$123382.3 in 2023, then jumped by 262.44% to $200423.6 in 2024, then sank by 326.02% to -$453000.3 in 2025, then increased by 26.04% to -$335027.6 in 2026.
• The last three Change in Receivables figures came in at -$335027.6 (Q1 2026), -$453000.3 (Q4 2025), and $86.3 billion (Q3 2025), per Business Quant data.